VJHemOnc is committed to improving our service to you

ERIC 2020 | Identifying novel biomarkers and advancing the classification system in CLL

VJHemOnc is committed to improving our service to you

Andreas Agathangelidis

Andreas Agathangelidis, PhD, Center for Research and Technology Hellas, Thermi, Greece, discusses the two major goals of current chronic lymphocytic leukemia (CLL) research; identifying novel biomarkers and advancing the current classification system. There has been fruitful research in somatic analysis to identify more CLL biomarkers. By analyzing B-cell receptor stereotypy, specific subgroups with similar immunoglobulin genes have been identified. As unique and specific disease variants at a biological and clinical level are identified, accurate treatment can therefore be administered. This interview took place during the European Research Initiative on CLL (ERIC) International Virtual Meeting 2020.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter